In a proof-of-concept, randomized clinical trial comparing continuation of long-term Tamsulosin treatment with a matching placebo among older men with BPH, YCSF researchers found that approximately 1 in 3 participants receiving Tamsulosin therapy had minimal or no effect from the Tamsulosin therapy versus a placebo on urinary symptoms.